Revelation Biosciences Net Worth
Revelation Biosciences Net Worth Breakdown | REVBW |
Revelation Biosciences Net Worth Analysis
Revelation Biosciences' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Revelation Biosciences' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Revelation Biosciences' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Revelation Biosciences' net worth analysis. One common approach is to calculate Revelation Biosciences' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Revelation Biosciences' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Revelation Biosciences' net worth. This approach calculates the present value of Revelation Biosciences' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Revelation Biosciences' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Revelation Biosciences' net worth. This involves comparing Revelation Biosciences' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Revelation Biosciences' net worth relative to its peers.
Enterprise Value |
|
To determine if Revelation Biosciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Revelation Biosciences' net worth research are outlined below:
| Revelation Biosciences had very high historical volatility over the last 90 days | |
| Revelation Biosciences has some characteristics of a very speculative penny stock | |
| Revelation Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (120.25 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Revelation Biosciences has accumulated about 4.14 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.79, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Revelation Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Revelation Bio Achieves Key Manufacturing Milestone for Kidney Disease Drug Trial REVB Stock News - StockTitan |
Project Revelation Biosciences' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (1.30) | (1.24) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.02) | (0.02) |
When accessing Revelation Biosciences' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Revelation Biosciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Revelation Biosciences' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Revelation Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Revelation Biosciences. Check Revelation Biosciences' Beneish M Score to see the likelihood of Revelation Biosciences' management manipulating its earnings.
Evaluate Revelation Biosciences' management efficiency
The company has return on total asset (ROA) of (0.5098) % which means that it has lost $0.5098 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.7002) %, meaning that it generated substantial loss on money invested by shareholders. Revelation Biosciences' management efficiency ratios could be used to measure how well Revelation Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.01 in 2024. Return On Capital Employed is likely to climb to -1.24 in 2024. At this time, Revelation Biosciences' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 198.9 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 61.8 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 29.16 | 27.70 | |
| Tangible Book Value Per Share | 29.16 | 27.70 | |
| Enterprise Value Over EBITDA | 89.98 | 94.48 | |
| Price Book Value Ratio | 0.52 | 0.54 | |
| Enterprise Value Multiple | 89.98 | 94.48 | |
| Price Fair Value | 0.52 | 0.54 | |
| Enterprise Value | -1.9 M | -1.8 M |
Revelation Biosciences' management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Return On Equity (2.70) |
Revelation Biosciences Earnings per Share Projection vs Actual
Revelation Biosciences Corporate Management
| James Rolke | CEO Director | Profile | |
| Carol Odle | Director Projects | Profile | |
| Chester III | Chief Officer | Profile | |
| Sandra Vedrick | Vice Relations | Profile |
Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.